UNUM THERAPEUTICS INC - COM (UMRX)

CUSIP: 903214104

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
10,090,960
Share change
+998,090
Total reported value
$4,641,017
Price per share
$0.46
Number of holders
22
Value change
+$465,842
Number of buys
6
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 903214104?
CUSIP 903214104 identifies UMRX - UNUM THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNUM THERAPEUTICS INC - COM (UMRX) as of Q2 2020

As of 30 Jun 2020, UNUM THERAPEUTICS INC - COM (UMRX) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,090,960 shares. The largest 10 holders included Atlas Venture Associates IX, LLC, New Leaf Venture Partners, L.L.C., RENAISSANCE TECHNOLOGIES LLC, CHI Advisors LLC, FIL Ltd, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, ACADIAN ASSET MANAGEMENT LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.